Home LiteratureArticle Details
PMID: 2881849 Published · ppublish English Journal Article

Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species.

Gut ·Vol. 28 ·No. 2 ·1987-02-00 ·Pages 190-5

Miyachi Y, Yoshioka A, Imamura S, Niwa Y

Abstract

The relative in vitro anti-oxidant efficacy of sulphasalazine (salicylazosulphapyridine, SASP) and its metabolites (5-aminosalicylic acid, 5-ASA; sulphapyridine, SP) was examined by studying their effects on the generation of reactive oxygen species (ROS) using zymosan-stimulated polymorphonuclear leucocytes (PMNs) and a cell free, xanthine-xanthine oxidase system. Salicylazosulphapyridine, 5-ASA, and SP showed anti-oxidant effects to the various degrees. In particular, production of OH, which is one of the most potent reactive oxygen species, was remarkably suppressed by 5-ASA dose relatedly. These findings suggest that SASP and its metabolites play an important role in the inhibition of respiratory bursts. As the potent products of the respiratory burst by polymorphonuclear leucocytes are thought to be important inflammatory mediators, suppression of toxic reactive oxygen species generation by these agents may partly explain the therapeutic efficacy of SASP in ulcerative colitis, which is characterised by an acute mucosal inflammation dominated by polymorphonuclear leucocytes accumulation.

MeSH Terms
Adult Aminosalicylic Acids/pharmacology Antioxidants/pharmacology Cell-Free System/drug effects Dose-Response Relationship, Drug Humans In Vitro Techniques Luminescent Measurements Mesalamine Neutrophils/drug effects,metabolism Sulfapyridine/pharmacology Sulfasalazine/pharmacology Superoxides/metabolism Xanthine Oxidase/metabolism Xanthines/metabolism Zymosan
Chemicals
Aminosalicylic Acids Antioxidants Xanthines Superoxides Sulfasalazine Mesalamine Zymosan Xanthine Oxidase Sulfapyridine
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Miyachi Y
Yoshioka A
Imamura S
Niwa Y
References (37)
37 references, click to expand
  1. Salicylate other than 5-aminosalicylic acid ineffective in ulcerative colitis.
    Lancet. 1978 Nov 4;2(8097):993 PMID: 82016
  2. Determination of prostaglandin synthetase activity in rectal biopsy material and its significance in colonic disease.
    Gut. 1978 Oct;19(10):875-7 PMID: 101423
  3. Prostaglandin synthetase activity in acute ulcerative colitis: effects of treatment with sulphasalazine, codeine phosphate and prednisolone.
    Gut. 1979 Sep;20(9):802-5 PMID: 40848
  4. The effect of sulfasalazine and its active components on human polymorphonuclear leukocyte function in relation to ulcerative colitis.
    Acta Med Scand. 1979;206(6):451-7 PMID: 43662
  5. Effects of indomethacin, 5,8,11,14-eicosatetraynoic acid, and p-bromophenacyl bromide on lysosomal enzyme release and superoxide anion generation by human polymorphonuclear leukocytes.
    Biochem Pharmacol. 1980 Feb 15;29(4):533-8 PMID: 6245654
  6. Effects of sulphasalazine and its metabolites on prostaglandin synthesis, inactivation and actions on smooth muscle.
    Br J Pharmacol. 1980 Apr;68(4):719-30 PMID: 6103724
  7. Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease.
    N Engl J Med. 1980 Dec 25;303(26):1499-502 PMID: 6107853
  8. Prostaglandin synthesis inhibitors in ulcerative colitis: flurbiprofen compared with conventional treatment.
    Prostaglandins. 1981 Mar;21(3):417-25 PMID: 6112777
  9. Ischemic injury in the cat small intestine: role of superoxide radicals.
    Gastroenterology. 1982 Jan;82(1):9-15 PMID: 6273253
  10. Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils.
    J Clin Invest. 1982 Feb;69(2):494-7 PMID: 6120182
  11. Selective actions of aspirin- and sulphasalazine-like drugs against prostaglandin synthesis and breakdown.
    Biochem Pharmacol. 1982 Mar 15;31(6):969-71 PMID: 6123327
  12. Auto-oxidative damage in Behçet's disease--endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils.
    Clin Exp Immunol. 1982 Jul;49(1):247-55 PMID: 7127901
  13. Arachidonic acid-induced chemiluminescence of human polymorphonuclear leukocytes.
    Biochem Biophys Res Commun. 1982 Aug;107(3):779-84 PMID: 6814431
  14. Increased hydroxyl radical generation by normal polymorphonuclear leukocytes incubated in sera from patients with leukocytoclastic vasculitis.
    Arch Dermatol Res. 1982;274(1-2):65-71 PMID: 7165369
  15. Effects of thalidomide on the generation of oxygen intermediates by zymosan-stimulated normal polymorphonuclear leukocytes.
    Arch Dermatol Res. 1982;274(3-4):363-7 PMID: 7165380
  16. Effects of psoriatic sera on the generation of oxygen intermediates by normal polymorphonuclear leucocytes.
    Arch Dermatol Res. 1983;275(1):23-6 PMID: 6847242
  17. Hydroxyl-free radicals and anti-inflammatory drugs: biological inactivation studies and reaction rate constants.
    Biochem Pharmacol. 1983 Jul 1;32(13):2109-11 PMID: 6307311
  18. Colonic azodisalicylate metabolism determined by in vivo dialysis in healthy volunteers and patients with ulcerative colitis.
    Gastroenterology. 1984 Jun;86(6):1496-500 PMID: 6143704
  19. Dissociation of the inhibitory effect of dapsone on the generation of oxygen intermediates--in comparison with that of colchicine and various scavengers.
    Biochem Pharmacol. 1984 Aug 1;33(15):2355-60 PMID: 6087824
  20. Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls.
    Gut. 1984 Nov;25(11):1271-8 PMID: 6149981
  21. Neutrophil-generated active oxygens in linear IgA bullous dermatosis.
    Arch Dermatol. 1985 Jan;121(1):73-8 PMID: 3881090
  22. Salazosulfapyridine and non-steroidal antiinflammatory drugs do not inhibit soybean lipoxygenase.
    Biochem Pharmacol. 1985 Jan 1;34(1):148-9 PMID: 2857082
  23. Auto-oxidative damage in cement dermatitis.
    Arch Dermatol Res. 1985;277(4):288-92 PMID: 2988461
  24. Erythema multiforme: a possible pathogenetic role of increased reactive oxygen species.
    J Clin Lab Immunol. 1986 Jan;19(1):11-4 PMID: 3517342
  25. Distribution studies of salicylazosulfapyridine and its metabolites.
    Gastroenterology. 1973 Feb;64(2):240-5 PMID: 4405598
  26. Effect of cytochalasin B on response of human polymorphonuclear leukocytes to zymosan.
    J Cell Biol. 1973 Apr;57(1):237-40 PMID: 4691395
  27. Drug therapy: Sulfasalazine.
    N Engl J Med. 1975 Jul 3;293(1):20-3 PMID: 236516
  28. Letter: Prostaglandins, ulcerative colitis, and sulphasalazine.
    Lancet. 1975 Nov 15;2(7942):988 PMID: 53480
  29. Phagocytic activation of a luminol-dependent chemiluminescence in rabbit alveolar and peritoneal macrophages.
    Biochem Biophys Res Commun. 1976 Mar 8;69(1):245-52 PMID: 1259763
  30. Elaboration of toxic oxygen by-products by neutrophils in a model of immune complex disease.
    J Clin Invest. 1976 Apr;57(4):836-41 PMID: 181401
  31. Inhibition of superoxide anion production in macrophages by anti-inflammatory drugs.
    Biochem Pharmacol. 1976 Jul 1;25(13):1473-80 PMID: 8043
  32. H2O2 release from human granulocytes during phagocytosis. Relationship to superoxide anion formation and cellular catabolism of H2O2: studies with normal and cytochalasin B-treated cells.
    J Clin Invest. 1977 Dec;60(6):1266-79 PMID: 199619
  33. An experiment to determine the active therapeutic moiety of sulphasalazine.
    Lancet. 1977 Oct 29;2(8044):892-5 PMID: 72239
  34. The biology and pathology of oxygen radicals.
    Ann Intern Med. 1978 Jul;89(1):122-7 PMID: 208444
  35. Ethylene formation by polymorphonuclear leukocytes. Role of myeloperoxidase.
    J Exp Med. 1978 Aug 1;148(2):490-506 PMID: 212502
  36. Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.
    Gastroenterology. 1978 Oct;75(4):638-40 PMID: 30669
  37. Prostaglandins and ulcerative colitis.
    Gastroenterology. 1979 May;76(5 Pt 1):1083 PMID: 374175
Article Info
Journal
Gut
Abbr.
Gut
ISSN
0017-5749
Published
1987-02-00
Pages
190-5
Language
English
Region
England
NLM ID
2985108R
PMCID
PMC1432978
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]